Hsbc Holdings »

Crispr Therapeutics shares owned by Hsbc Holdings

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Hsbc Holdings from 13F filings

Historical chart of Hsbc Holdings investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Hsbc Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Hsbc Holdings

Quarter filed Position value Share count Share price at filing
2024-06-30 $1.4M 27k 53.94
2022-06-30 $721k 12k 62.42
2022-03-31 $1.2M 20k 62.73
2021-12-31 $1.4M 19k 76.99
2021-09-30 $1.5M 13k 114.05
2021-06-30 $1.8M 11k 161.94
2021-03-31 $3.2M 27k 121.71
2020-12-31 $1.7M 11k 154.47
2020-09-30 $390k 4.6k 85.30
2020-06-30 $202k 2.8k 73.40
2020-03-31 $1.1M 27k 41.68